Página inicialPodcasts FDA Drug Safety PodcastsFDA adds Boxed Warning for increased risk of severe hypocalcemia in patients with advanced chronic kidney disease taking osteoporosis medicine Prolia (denosumab)FDA adds Boxed Warning for increased risk of severe hypocalcemia in patients with advanced chronic kidney disease taking osteoporosis medicine Prolia (denosumab)6 de fevereiro de 2024FDA Drug Safety PodcastsPlayOuvir episódio
